3WlNTERBOURN C C. Reconciling the chemistry and biology of reactive oxygen species[J]. Nat Chem Biol, 2008, 4(5): 278-286.
4NISHIKAWA M. Reactive oxygen species in tumor metastasis[J]. Cancer Lett, 2008, 266(1): 53-59.
5KNIGHT J A, ONAY U V, WELLS S, et al. Genetic variants of GPXl and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry[J]. Cancer Epidemiol Biomarkers Prev, 2004, 13(1): 146-149.
6CHOI J Y, NEUHOURSER M L, BARNETT M J, et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort[J]. Carcinogenesis, 2008, 29(5): 964-970.
7MURPHY S J, HUGHES A E, PATTERSON C C, et al. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma[J]. Carcinogenesis, 2007, 28(6): 12,23-1328.
8TONG S Y, LEE J M, SONG E S, et al. Functional polymorphism in manganese superoxide dismutase and antioxidant status: their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer[J]. Gynecol Oncol, 2009, 115(2): 272-276.
9WANG L I, MILLER D P, SAI Y, et al. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk[J]. J Natl Cancer Inst, 2001, 93 (23): 1818-1821.
10HUNG R J, BRENNAN P, MALAVILLE C, et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk[J]. Carcinogenesis, 2004, 25(6): 973-978.
